Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
letter
. 2005 Jun;49(6):2573. doi: 10.1128/AAC.49.6.2573.2005

The ORF1 Gene Located on the Class-1-Integron-Associated Gene Cassette Actually Represents a Novel Fosfomycin Resistance Determinant

Jun Yatsuyanagi 1,*, Shioko Saito 1, Takayuki Konno 1, Seizaburo Harata 1, Noriyuki Suzuki 1, Ken-ichi Amano 1
PMCID: PMC1140483  PMID: 15917578

The class 1 integrons are genetic elements capable of integrating gene cassettes by a site-specific recombination mechanism (1). Gene cassettes are mobile units composed of a gene, most often an antibiotic resistance gene, and a recombination site, the 59-base element (1). We have previously characterized a class 1 integron containing a VIM-2-type metallo-β-lactamase gene, blaVIM-2, an aacA4 gene, and an unknown function gene, designated as ORF1, which was identified in a Pseudomonas aeruginosa clinical isolate strain Mβ-7 (6). Partridge and Hall (5) recently searched using the predicted sequences of the proteins encoded by gene cassette-encoded open reading frames and revealed that two proteins encoded by ORF1 and orf “i” (2) genes showed a similarity with the amino acid sequence, along with the presence of a number of conserved key amino acids, of known fosfomycin resistance determinants including FosA, FosB, PA1129, lmo1702, and mlr3345. Based on these search results, they proposed that both ORF1 and orf “i” genes are likely to confer fosfomycin resistance. To prove this hypothesis, we cloned the ORF1 gene and constructed an Escherichia coli transformant to examine its antibiotic resistance phenotype.

The ORF1 gene was amplified from P. aeruginosa strain Mβ-7 by PCR using primers ORF1 Exp5 EcoRI (5′-TCG GAA TTC AAT GAT TAC CGG CAT CAA TCA C-3′) and ORF1 Exp3 HindIII (5′-TTA AAG CTT CGT CAG CTC CAC ACC AGC CCC TT-3′). These primers were designed to clone the ORF1 gene to be in frame with the lacZ gene on the cloning vector pBCSK+ to construct transformant able to express the ORF1 fusion protein. Since these primers prime at the beginning and the end of the ORF1 coding region, respectively, all regulatory signals from the original P. aeruginosa gene were eliminated. The amplified fragment containing the ORF1 gene was digested with EcoRI and HindIII and cloned into pBCSK+ to form the recombinant plasmid, ORF1:pBCSK+. E. coli DH5 was transformed with the ORF1:pBCSK+ plasmid to form E. coli DH5 ORF1:pBCSK+. The transformants were selected on L agar plates containing 30 μg/ml chloramphenicol and 20 mM IPTG (isopropyl-β-d-thiogalactopyranoside). Antibiotic resistance phenotypes of the E. coli DH5 ORF1:pBCSK+, P. aeruginosa strain Mβ-7, and E. coli DH5 containing pBCSK+ (E. coli DH5 pBCSK+) were determined by the broth microdilution method according to the guidelines of the National Committee for Clinical Laboratory Standards (3, 4) using commercially available plates, Dryplate “Eiken” DP-21 and DP-25 (Eiken Kagaku Co., Tokyo, Japan).

P. aeruginosa strain Mβ-7 and E. coli DH5 ORF1:pBCSK+ showed a >32 μg/ml MIC of fosfomycin, while the control strain E. coli DH5 pBCSK+ was sensitive to this antibiotic. These results prove the hypothesis proposed by Partridge and Hall (5) that the ORF1 gene is the novel fosfomycin resistance determinant. It is important to clarify prevalence of this novel fosfomycin resistance determinant.

REFERENCES

  • 1.Fluit, A. C., and F. J. Schmitz. 1999. Class 1 integrons, gene cassettes, mobility, and epidemiology. Eur. J. Clin. Microbiol. Infect. Dis. 18:761-770. [DOI] [PubMed] [Google Scholar]
  • 2.Lee, K., J. B. Lim, J. H. Yum, D. Yong, Y. Chong, J. M. Kim, and D. M. Livermore. 2002. blaVIM-2 cassette-containing novel integrons in metallo-β-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital. Antimicrob. Agents Chemother. 46:1053-1058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard M7-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
  • 4.National Committee for Clinical Laboratory Standards. 2003. MIC testing supplement tables. M100-S13 (M7). National Committee for Clinical Laboratory Standards, Wayne, Pa.
  • 5.Partridge, S. R., and R. M. Hall. 2005. Gene cassettes potentially encoding fosfomycin resistance determinants. Antimicrob. Agents Chemother. 49:860-861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Yatsuyanagi, J., S. Saito, S. Harata, N. Suzuki, Y. Ito, K. Amano, and K. Enomoto. 2004. Class 1 integron containing metallo-β-lactamase gene blaVIM-2 in Pseudomonas aeruginosa clinical strains isolated in Japan. Antimicrob. Agents Chemother. 48:626-628. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES